2022 spells change for EU pharmaceutical legislation
European Pharmaceutical Review
JUNE 24, 2022
The actual legislation will then have a certain implementation period and will be prospective, for the most part. He focuses his practice on EU regulatory affairs, litigation and competition law issues affecting the life sciences sector in Europe. Maarten has significant competition law experience in a variety of sectors.
Let's personalize your content